Happy Holidays from Etiometry!

As we wind down another year I find it helpful to look back at the past 12 months as a method of looking forward into what to expect over the next year. This has been a tremendous year for Etiometry, and I’m grateful for all the experiences we’ve had deploying the Etiometry Platform and helping customers reduce costs and improve care in pediatric ICUs. We began the year by announcing…

How is Our Risk Analytics Engine Technology a Platform for Analytics?

There has been a longstanding vision in the digital health industry of what it means to be an analytics platform, and it goes like this: get as much of the data as possible and give it to applications that can transform it to clinical insights. In this single-focus philosophy, anyone who can get to the data claims to have a platform as long as they enable other applications to provide…

Ready for a Career with Etiometry?

Are you interested in joining the Etiometry team to help us convert medical data into actionable information that allows clinicians to improve treatment and reduce the cost of medical care? By joining our rapidly expanding company, you will be at the forefront of clinical innovation. Etiometry provides successful candidates with the opportunity to work with a passionate team of innovators—both within Etiometry as well as researchers at some of the…

An Aerospace Engineering View of Medicine

I recently had the privilege of touring the Airbus final assembly line in Toulouse, France and had the opportunity to remind myself how complex, fascinating, and impressive it is to build an aircraft. There is nothing more exciting for an aerospace engineer than to see the product of millions of hours of development and manufacturing split between dozens of countries and see tens-of-thousands of parts come together into a marvel…

Intelligent Monitoring of the Risk of Inadequate Oxygen Delivery Expands to Support Patients up to 12 Years Old

In 2016, Etiometry received U.S. Food & Drug (FDA) 510(k) clearance for the first of our Risk Analytics Algorithms. The Inadequate Oxygen Delivery (IDO2) Index is the first of many Etiometry algorithms that we are bringing to market. With our IDO2 algorithm embedded within the Etiometry platform, doctors and nurses can quickly assess the risk of inadequate oxygen delivery alongside traditional measures of the patient’s status in a manner that clearly visualizes…

Etiometry Receives FDA 510(k) Clearance to Expand the Indications on Its IDO2 Index Powered by Risk Analytics

Hospitals Can Expand the Intelligent Monitoring Provided by Etiometry’s Inadequate Oxygen Delivery Index to Patients Up to 12 Years of Age BOSTON, June 12, 2017— Etiometry, a pioneering leader in next-generation patient monitoring, has received FDA Clearance for its Inadequate Oxygen Delivery (IDO2) Index for monitoring ICU patients 12 years or younger. Originally cleared by the FDA in 2016 for tracking the clinical risk of inadequate oxygen delivery to neonatal…

Human Factors in ICUs

I recently attended the Human Factors and Ergonomics in Health Care event in New Orleans, which offered cutting-edge presentations and workshops on emerging issues in healthcare human factors and the challenges facing us in the near future. It was sponsored by the Human Factors and Ergonomics Society (HFES), whose mission is, “To promote the discovery and exchange of knowledge concerning the characteristics of human beings that are applicable to the…

The Role of Artificial Intelligence in ICUs

A recent article in Wired Magazine discusses Etiometry and the importance of developing impactful analytics to improve the quality of care in the ICU. While the article focused on artificial intelligence (AI) and whether it would in some ways eventually automate physician responsibilities, it reached the following logical conclusion: “If we are able to develop systems that enhance their [physicians] capabilities and allow them to provide their patients better care,…

Etiometry Launches Persistent Display Mode for Advanced ICU Visualization and Analytics

Etiometry has introduced Persistent Display functionality that allows hospital care givers to view near real-time patient trend information continuously by the bedside to improve care delivery. (See related press release). Persistent Display is now bundled into our T3 Visualization & Data Aggregation software, an FDA-cleared software application to collect, store, and visualize ICU data in near real-time. T3 operates in two different “Modes” of visualization: Individual User Mode Persistent Display…